| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | dabrafenib | CTRPv2 | pan-cancer | AAC | 0.002 | 1 |
| mRNA | MS-275 | GDSC1000 | pan-cancer | AAC | -0.0022 | 1 |
| mRNA | BRD-K26531177 | CTRPv2 | pan-cancer | AAC | -0.0015 | 1 |
| mRNA | RG-108 | CTRPv2 | pan-cancer | AAC | 0.0014 | 1 |
| mRNA | erismodegib | CTRPv2 | pan-cancer | AAC | 0.0014 | 1 |
| mRNA | IPA-3 | GDSC1000 | pan-cancer | AAC | -0.00093 | 1 |
| mRNA | trifluoperazine | CTRPv2 | pan-cancer | AAC | 0.00094 | 1 |
| mRNA | C6-ceramide | CTRPv2 | pan-cancer | AAC | -0.00089 | 1 |
| mRNA | ZG-10 | GDSC1000 | pan-cancer | AAC | -0.00086 | 1 |
| mRNA | Gemcitabine | gCSI | pan-cancer | AAC | 0.001 | 1 |